Investigadores de la USC identifican compuestos que atacan la inflamación cerebral del alzhéimer

26 de mayo de 2026

Reportado por IA

Científicos de la Universidad del Sur de California han hallado compuestos experimentales que podrían reducir la inflamación cerebral dañina asociada con la enfermedad de Alzheimer. El trabajo se centra en la enzima cPLA2 y en las personas portadoras del gen de alto riesgo APOE4.

Investigadores de la Universidad del Sur de California identificaron compuestos que inhiben selectivamente la cPLA2, una enzima vinculada a la inflamación en el cerebro. Los hallazgos fueron publicados en la revista npj Drug Discovery en 2026. El equipo relacionó una mayor actividad de la cPLA2 con un mayor riesgo de alzhéimer entre los portadores del gen APOE4, aunque la enzima también contribuye al funcionamiento normal del cerebro.

Oregon State researchers track copper-driven amyloid clumping in real time, testing a copper-selective chelator

7 de abril de 2026 Reportado por IA Imagen generada por IA Verificado por hechos

Oregon State University scientists report they have monitored, second by second, how copper ions promote aggregation of amyloid-beta—an Alzheimer’s-associated protein—and how different metal-binding molecules can disrupt or reverse that clumping, using a fluorescence anisotropy approach described in a study published in ACS Omega.

Scientists call for multi-pronged strategies against Alzheimer's

A team of researchers led by Professor Yan-Jiang Wang has published a review arguing that Alzheimer's disease requires integrated treatments targeting multiple factors, not single causes. New drugs like lecanemab and donanemab offer modest benefits by slowing decline, but fall short of reversal. The paper, in Science China Life Sciences, emphasizes genetics, aging, and systemic health alongside amyloid-beta and tau proteins.

Study links Alzheimer's origins to peripheral inflammation

5 de marzo de 2026 Reportado por IA

A new genomic analysis suggests that Alzheimer's disease may begin with inflammation in organs like the skin, lungs, or gut, potentially decades before brain symptoms appear. Researchers analyzed genetic data from hundreds of thousands of people and found risk genes more active outside the brain. This perspective could reshape prevention and treatment strategies.

Salud

Cochrane review questions benefits of anti-amyloid Alzheimer’s drugs

Salud

New blood test spots Alzheimer's via protein shape changes

Salud

UCLA scientists reverse liver damage in mice by removing zombie cells

Study links microbial glycogen in the gut to inflammation in C9orf72-associated ALS and frontotemporal dementia

Researchers at Case Western Reserve University report that some gut bacteria can make unusually inflammatory forms of glycogen and that this microbial glycogen can trigger immune activity linked to brain inflammation in models of disease tied to the C9orf72 mutation. In patient stool samples, the team found these glycogen forms more often in ALS and C9orf72-related frontotemporal dementia than in healthy controls, and enzymatically breaking down glycogen in the gut improved outcomes in mice.

Higher meat intake slows Alzheimer's decline for APOE4 carriers, Karolinska study shows

19 de marzo de 2026 Reportado por IA

Older adults carrying high-risk APOE4 gene variants experienced slower cognitive decline and lower dementia risk with higher meat consumption, according to a Karolinska Institutet study of over 2,100 participants tracked for up to 15 years. Findings suggest diet's effects on brain health vary by genetics, challenging one-size-fits-all advice.

20 de mayo de 2026 09:20

Investigadores de la USC identifican compuestos que atacan la inflamación cerebral del alzhéimer

Artículos relacionados

Oregon State researchers track copper-driven amyloid clumping in real time, testing a copper-selective chelator

Scientists call for multi-pronged strategies against Alzheimer's

Study links Alzheimer's origins to peripheral inflammation

Cochrane review questions benefits of anti-amyloid Alzheimer’s drugs

New blood test spots Alzheimer's via protein shape changes

UCLA scientists reverse liver damage in mice by removing zombie cells

Study links microbial glycogen in the gut to inflammation in C9orf72-associated ALS and frontotemporal dementia

Higher meat intake slows Alzheimer's decline for APOE4 carriers, Karolinska study shows

Indiana university team targets idol enzyme to treat alzheimer's

Nanoparticles reduced amyloid-β and improved cognition in an Alzheimer’s mouse model, researchers report

Mechanic with Alzheimer's mutation avoids disease through heat exposure

Scientists restore memory in Alzheimer's mice by blocking PTP1B

Strategies to Reduce Peripheral Inflammation and Alzheimer's Risk

Scientists discover brain's tau cleanup system for Alzheimer's

Este sitio web utiliza cookies